30 Cases of Clinical Study for Fu's Subcutaneous Needling Therapy on the Treatment of Patients with Supraspinatus Calcification Tendinitis
Objective:To observe the clinical efficacy for Fu's subcutaneous needling therapy on the treatment of patients with supraspinatus calcification tendinitis.Methods:A total of 30 patients with supraspinatus calcification tendinitis from July 2021 to June 2023 were analyzed and treated with Fu's subcutaneous.Then the clinical efficacy,pain visual analogue scale(VAS)score,Constant-Murley shoulder function scale(CMS)score,blood and serum inflammatory factors(inter-leukin-1α(IL-1α),interleukin-33(IL-33))levels before and after treatment were observed to evaluate the therapeutic effi-cacy.Results:After treatment,the treatment of patients with the total effective rate was 96.67%,the VAS scores and serum inflammatory factor levels are lower,CMS scores higher ratings,the difference is statistically significant difference(P<0.05).Conclusion:Fu's subcutaneous needling therapy can effectively treat supraspinatus calcification tendinitis,help to relieve shoulder joint pain,reduce inflammatory response,promote disease recovery,and improve the activity of shoulder joint function of patients.